Bryan Giraudo
2020
In 2020, Bryan Giraudo earned a total compensation of $2M as Chief Operating Officer and Financial Officer at Gossamer Bio, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $176,400 |
|---|---|
| Option Awards | $745,316 |
| Salary | $416,667 |
| Stock Awards | $676,575 |
| Total | $2,014,958 |
Giraudo received $745.3K in option awards, accounting for 37% of the total pay in 2020.
Giraudo also received $176.4K in non-equity incentive plan, $416.7K in salary and $676.6K in stock awards.
Rankings
In 2020, Bryan Giraudo's compensation ranked 5,470th out of 13,090 executives tracked by ExecPay. In other words, Giraudo earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,470 out of 13,090 | 58th |
Division Manufacturing | 2,251 out of 5,624 | 60th |
Major group Chemicals And Allied Products | 896 out of 2,257 | 60th |
Industry group Drugs | 773 out of 1,957 | 61st |
Industry Pharmaceutical Preparations | 578 out of 1,462 | 61st |
Source: SEC filing on April 27, 2022.
Giraudo's colleagues
We found two more compensation records of executives who worked with Bryan Giraudo at Gossamer Bio in 2020.